These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9012931)
1. Risk of cytomegalovirus infection after peripheral blood stem cell transplantation. Sakuma H; Hosoya M; Kanno H; Kikuta A; Konno K; Kawano Y; Takaue Y; Shigeta S; Suzuki H Bone Marrow Transplant; 1997 Jan; 19(1):49-53. PubMed ID: 9012931 [TBL] [Abstract][Full Text] [Related]
2. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction]. Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of cytomegalovirus infection with the polymerase chain reaction and antigenemia in patients after allogenic peripheral stem cell transplantation--comparison of 318 paired samples]. Mayer J; Dvoráková D; Krahulová M; Vorlícek J; Adler J Cas Lek Cesk; 1999 Jul; 138(14):436-40. PubMed ID: 10566215 [TBL] [Abstract][Full Text] [Related]
4. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310 [TBL] [Abstract][Full Text] [Related]
5. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT. Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation. Sakamaki H; Yuasa K; Goto H; Tanikawa S; Akiyama H; Onozawa Y; Okamoto R; Maeda Y; Sasaki T; Kaku H; Tsuzuki S; Takamoto S; Mochida Y; Minematsu T; Minamishima Y Bone Marrow Transplant; 1997 Jul; 20(2):143-7. PubMed ID: 9244418 [TBL] [Abstract][Full Text] [Related]
7. Rapid detection cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid. Goto H; Yuasa K; Sakamaki H; Nakata K; Komuro I; Iguchi M; Okamura T; Ieki R; Tanikawa S; Akiyama H; Onozawa Y; Mochida Y Bone Marrow Transplant; 1996 May; 17(5):855-60. PubMed ID: 8733709 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants]. Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689 [TBL] [Abstract][Full Text] [Related]
9. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717 [TBL] [Abstract][Full Text] [Related]
10. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients. Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460 [TBL] [Abstract][Full Text] [Related]
11. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation. Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466 [TBL] [Abstract][Full Text] [Related]
12. [Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients]. Xu LP; Huang XJ; Guo NL; Ren HY; Zhang YC; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):407-9. PubMed ID: 14642176 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537 [TBL] [Abstract][Full Text] [Related]
14. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan. Kanda Y; Mineishi S; Saito T; Seo S; Saito A; Suenaga K; Ohnishi M; Niiya H; Nakai K; Takeuchi T; Kawahigashi N; Shoji N; Ogasawara T; Tanosaki R; Kobayashi Y; Tobinai K; Kami M; Mori S; Suzuki R; Kunitoh H; Takaue Y Bone Marrow Transplant; 2001 Feb; 27(4):437-44. PubMed ID: 11313674 [TBL] [Abstract][Full Text] [Related]
15. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation. Pumannova M; Roubalova K; Vitek A; Sajdova J Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775 [TBL] [Abstract][Full Text] [Related]
17. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors]. Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755 [TBL] [Abstract][Full Text] [Related]
18. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation. Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279 [TBL] [Abstract][Full Text] [Related]
19. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients. Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment. Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]